ID: ALA2368600

Max Phase: Preclinical

Molecular Formula: C10H11N7O4

Molecular Weight: 293.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [N-]=[N+]=N[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(O)ncnc21

Standard InChI:  InChI=1S/C10H11N7O4/c11-16-15-5-7(19)4(1-18)21-10(5)17-3-14-6-8(17)12-2-13-9(6)20/h2-5,7,10,18-19H,1H2,(H,12,13,20)/t4-,5+,7-,10-/m1/s1

Standard InChI Key:  XVJKHWMRWQMWOZ-GQTRHBFLSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 293.24Molecular Weight (Monoisotopic): 293.0873AlogP: -0.54#Rotatable Bonds: 3
Polar Surface Area: 162.28Molecular Species: ACIDHBA: 9HBD: 3
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: -10.39CX Basic pKa: 0.63CX LogP: -0.75CX LogD: -0.86
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.39Np Likeness Score: 1.00

References

1. Lin TS, Cheng JC, Ishiguro K, Sartorelli AC..  (1985)  Purine and 8-substituted purine arabinofuranosyl and ribofuranosyl nucleoside derivatives as potential inducers of the differentiation of the Friend erythroleukemia.,  28  (10): [PMID:3862866] [10.1021/jm00148a018]

Source